Multiple myeloma (first line) - bortezomib and thalidomide: appeal announcement
Appeal Announcement
The Institute have received one appeal from Janssen- Cilag.
The Appeal hearing took place at NICE, MidCity Place, 71 High Holborn, London WC1V 6NA on Monday 15 November 2010 at 10am.
The Institute awaits the decision of the Appeal Panel.
Multiple myeloma (first line) - bortezomib and thalidomide: appeal received
Multiple myeloma (first line) - bortezomib and thalidomide: initial scrutiny letter
Multiple myeloma (first line) - bortezomib and thalidomide: response to scrutiny letter
Multiple myeloma (first line) - bortezomib and thalidomide: final scrutiny letter
This page was last updated: 16 December 2010